We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. Show more
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.98 | -5.78640776699 | 51.5 | 51.76 | 45.1344 | 117564 | 46.31092332 | CS |
| 4 | -2.86 | -5.56636823667 | 51.38 | 53.41 | 42.83 | 96456 | 47.14511798 | CS |
| 12 | 17.66 | 57.2261827609 | 30.86 | 53.41 | 30.14 | 110203 | 43.81442244 | CS |
| 26 | 32.68 | 206.313131313 | 15.84 | 53.41 | 15.08 | 87391 | 35.14020841 | CS |
| 52 | 31.62 | 187.100591716 | 16.9 | 53.41 | 15.0001 | 84597 | 34.60438323 | CS |
| 156 | 31.62 | 187.100591716 | 16.9 | 53.41 | 15.0001 | 84597 | 34.60438323 | CS |
| 260 | 31.62 | 187.100591716 | 16.9 | 53.41 | 15.0001 | 84597 | 34.60438323 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
